Progressive Supranuclear Palsy Clinical Deficits Scale (PSP-CDS)
Assess clinical deficits in patients with Progressive Supranuclear Palsy.
Permission is required for each single use of the MDS Clinical Outcome Assessments.
The PSP-CDS was developed to assess clinical deficits in patients with Progressive Supranuclear Palsy (PSP). The scale measures severity of deficits in seven patient-relevant clinical domains: Akinesia-rigidity, Bradyphrenia, Communication, Dysphagia, Eye movements, Finger dexterity, and Gait & balance; each scored from 0 to 3.
With good sensitivity to change and well-defined clinical domains, the PSP-CDS is a valid and reliable scale that can be easily applied to a broad spectrum of PSP phenotypes equally.
This scale is expected to be useful for clinical care and research involving PSP, including observational and therapeutic trials relating to hallmark and variant PSP phenotypes.
Authors: Günter U. Höglinger, Ines Piot, Kerstin Schweyer, Gesine Respondek, Maria Stamelou, Philipp Sckopke, Thomas Schenk, Christopher G. Goetz, and Glenn T. Stebbins
Download original publication | View the Scale (PDF) Permission required for use
- Acronym: PSP-CDS
- Year Published: 2020
- Assessment Type: ClinRO
- Estimated Time to Complete: 4 minutes
- Available Translations: None
Eletronic builds: REDCap
To request permission to use this Rating Scale, please fill out a Permission Request Form.
Inclusive Language in Clinical Outcome AssessmentsHealthcare providers should tailor the language used in COAs to reflect each patient’s gender identity. In grammatically gendered languages, the practice includes making appropriate linguistic adjustments to ensure communication is respectful and inclusive throughout the assessment process. |
Related Publications
Piot I, Schweyer K, Respondek G, Stamelou M, Sckopke P, Schenk T, Goetz CG, Stebbins GT. Höglinger GU, and members of the DescribePSP study group, ProPSP study group, and MDS-endorsed PSP study group. The Progressive Supranuclear Paksy Clinical Deficits Scale. Movement Disorders. 2020 Jan; https://doi.org/10.1002/mds.27964
(Original Scale Publication)